Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study

スポンサーリンク

概要

• 論文の詳細を見る
• 2005-07-30

著者

• Nakajima Toshiaki

  東京医科歯科大学 疾患生命科学研究部ゲノム多様性

• Nakajima T

  Department Of Orthopedic Surgery University Of Occupational And Environmental Health

• Nakatsuka Kiyoshi

  Department Of Metabolism Endocrinology And Molecular Medicine Osaka City University Graduate School

• SHIRAKI Masataka

  Research Institute and Practice for Involutional Diseases

• OHASHI Yasuo

  Biostatistics Sciences, School of Health Science and Nursing Biostatistics, University of Tokyo

• Fukunaga Masao

  Department Of Nuclear Medicine Kawasaki Medical School

• Fukunaga Masao

  徳島大学 大学院ヘルスバイオサイエンス研究部運動機能外科学

• Fukunaga Masao

  Kawasaki Medical School Okayama Jpn

• Nishimura Taiji

  千葉大学 医学研究院泌尿器科

• Fujita Masayo

  Department Of Nuclear Medicine Kawasaki Medical School

• Kakikawa Taro

  Clinical Development Institute Banyu Pharmaceutical Co. Ltd.

• SHIRAKI Masataka

  Department of Internal Medicine, Research Institute and Practice for Involutional Diseases

• NAKAMURA TOSHITAKA

  University of Occupational and Environmental Health

• Fukunaga Masao

  Department Of Geriatric Medicine Graduate School Of Medicine The University Of Tokyo

• Shintani Masafumi

  Department Of Obstetrics And Gynecology Narakenritsu Mimuro Hospital

• Uchida Shinji

  旭化成株式会社 医薬臨床調査センター

• UCHIDA Shinji

  Clinical Development Institute, Banyu Pharmaceutical Co., Ltd.

• TANIGUCHI Tadaaki

  Clinical Development Institute, Banyu Pharmaceutical Co., Ltd.

• SHIMIZU Takafumi

  Clinical Development Institute, Banyu Pharmaceutical Co., Ltd.

• OKUYAMA Kotoba

  Clinical Development Institute, Banyu Pharmaceutical Co., Ltd.

• OKANIWA Masahiko

  Pharmaceutical Business Unit, Teijin Pharma Ltd.

• ARIZONO Hironori

  Pharmaceutical Business Unit, Teijin Pharma Ltd.

• NAGATA Koichi

  Pharmaceutical Business Unit, Teijin Pharma Ltd.

• SANTORA Arthur

  Merck Research Laboratories

• TOMOMITSU Tatsushi

  Kawasaki Medical School

• Okuyama Kotoba

  Clinical Development Institute Banyu Pharmaceutical Co. Ltd.

• Oh-hashi Yasuo

  Epidemiology And Biostatistics School Of Health Science Faculty Of Medicine University Of Tokyo

• Nakamura Tetsuro

  Department Of Endocrinology Tokyo Metropolitan Geriatric Hospital

• SHIMIZU Takafumi

  旭化成株式会社 医薬臨床調査センター

• TANIGUCHI Tadaaki

  旭化成株式会社 医薬臨床調査センター

• Shiraki Masataka

  Department Of Internal Medicine Research Institute And Practice For Involutional Diseases

• Okaniwa Masahiko

  Pharmaceutical Business Unit Teijin Pharma Ltd.

• Arizono Hironori

  Pharmaceutical Business Unit Teijin Pharma Ltd.

• Shiraki M

  成人病診療研究所

• Shiraki Masataka

  Research Institute And Practice For Involutional Disease

• Nakamura Toshitaka

  General Research Committee For Prevention Of Osteoporosis Ministry Of Health And Welfare Tokyo Hospi

• FUKUNAGA Masao

  Kawasaki Medical School

関連論文

• Genetic Association of Low-Density Lipoprotein Receptor-Related Protein 2 (LRP2) with Plasma Lipid Levels
• Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia
• ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population
• Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
• Association of a Sequence Variation in the Gene Encoding Adiponectin Receptor 1 (ADIPOR1) with Body Mass Index in the Japanese Population
• Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
• Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women
• Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
• Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
• Biochemical markers for the detection of bone metastasis in parients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• Promotion of Bone Formation by Fermented Soybean (Natto) Intake in Premenopausal Women
• Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals : a randomized controlled trial
• Report on the Japanese Orthopaedic Association's 3-year project observing hip fractures at fixed-point hospitals
• Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer
• Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series
• Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis
• Genomic Structure and Mapping of Human Orphan Receptor LXR Alpha : Upregulation of LXRa mRNA During Monocyte to Macrophage Differentiation
• Standard radial bone mineral density and physical factors in ordinary Japanese women
• Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
• Vitamin K_2 (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis
• Effect of Estriol on Bone Loss in Postmenopausal Japanese Women : A Multicenter Prospective Open Study
• Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
• Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm
• Genomic structure of the gene encoding human 3-hydroxy-3-methyl-glutaryl coenzyme A reductase : comparison of exon/intron organization of sterol-sensing domains among four related genes
• Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene
• Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
• Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
• Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
• Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
• Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals
• Genomic structure and chromosomal mapping of the human Site-1 protease (S1P) gene
• Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the SREBP cleavage-activating protein (SCAP) locus
• A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
• The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
• Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
• The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
• A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
• Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
• Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
• A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
• Diagnostic criteria for primary osteoporosis: year 2000 revision
• Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
• Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
• Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
• Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
• A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteopotosis
• Novel single nucleotide polymorphisms of the human nuclear factor kappa-B 2 gene identified by sequencing the entire gene
• Novel single nucleotide polymorphisms of the human colony-stimulating factor 2 (CSF2) gene identified by sequencing the entire gene
• Five novel single-nucleotide polymorphisms of human interferon gamma identified by sequencing the entire gene
• Technetium-99m Methoxyisobutyl Isonitrile Scintigraphy of Bone Metastasis in Three Patients with Differentiated Thyroid Cancer
• Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis
• Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy ; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline
• Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate : advantage of free form of DPD over total DPD in predicting treatment efficacy
• False-positive magnetic resonance imaging skeletal survey in a patient with sporadic hypophosphatemic osteomalacia
• Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
• Clinical application of immunoassay for urinary total excretion of deoxypyridinoline in patients with osteoporosis
• Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
• Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
• Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus
• Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
• Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
• Diagnostic criteria of primary osteoporosis
• Nationwide incidence survey of femoral neck fracture in Japan, 1992
• Guidelines for diagnosis and management of Paget's disease of bone in Japan
• Prevalence and clinical features of Paget's disease of bone in Japan
• Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities
• Fractal Analysis of Bone Architecture at Distal Radius
• Association of Bone Metabolism Regulatory Factor Gene Polymorphisms With Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine and Its Severity
• Evolution of understanding of genetics of Paget's disease of bone and related diseases
• Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy
• Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
• Validation of the Japanese Osteoporosis Quality of Life Questionnaire
• Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
• Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
• Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
• Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study
• Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study
• A polymorphic variant at the Werner helicase(WRN)gene is associated with bone density, but not spondylosis, in postmenopausal women
• A common Ile796Val polymorphism of the human SREBP cleavage-activating protein (SCAP) gene
• The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
• Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis
• Nationwide one-decade survey of hip fractures in Japan
• Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
• Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
• Abnormal Bone Metabolism in a Postmenopausal Woman with Grave's Disease on Antithyroid Therapy : A Case Report
• Effect of 1α-Hydroxyvitamin D_3 on Loss of Bone Mineral Density Immediately after Artificial Menopause
• 健康関連QOLが生存へ与える影響の同時モデリングによる評価
• ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
• Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
• Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures
• Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis
• Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
• Effect of disuse on bone mineral content, lean mass, and fat mass in osteoarthritic patients
• Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
• Breast arterial calcification and hypertension associated with vertebral fracture

もっと見る 閉じる

スポンサーリンク